Imatinib mesylate versus allogeneic BMT for patients with chronic myeloid leukemia in first chronic phase
暂无分享，去创建一个
H. Bittencourt | A. Azambuja | R. Pasquini | L. Fogliatto | L. Silla | A. Paz | V. Funke | A. Macedo | N. Clementino | S. Magalhaes | D. Setubal | J. Ruiz | Ricardo Pasquini | Henrique Bittencourt | Simone Silva Magalhaes | Antonio Macedo | Ana Paula de Azambuja | A. Macedo